期刊文献+

双侧原发性乳腺癌13例临床分析 被引量:3

CLINICAL ANALYSIS OF 13 CASES OF PRIMARY BILATERAL BREAST CANCER
下载PDF
导出
摘要 目的探讨双侧原发性乳腺癌发病因素、分子分型、手术方式等,并对其预后进行评估。方法分析双侧原发性乳腺癌和同期单侧乳腺癌患者的发病年龄;分析双侧原发性乳腺癌临床病理资料,根据雌激素受体(estrogen receptor,ER)、孕激素受体(progesterone receptor,PR)和人表皮生长因子受体-2(human epidermal growthfactor receptor2,HER-2)的表达情况将双侧乳腺癌分为4种分子亚型,即Luminal A型、Luminal B型、HER-2型和三阴性乳腺癌。分析各分子亚型的临床病理特征;分析双侧原发性乳腺癌和同期单侧乳腺癌治疗方式。结果双侧原发性乳腺癌比同期单侧乳腺癌的患者年轻。双侧原发性乳腺癌的三阴性乳腺癌组织学Ⅲ级患者明显多于其他亚型(P<0.05),各分子亚型在淋巴结转移上差异无统计学意义(P>0.05)。双侧原发性乳腺癌保乳手术比例与同期单侧乳腺癌保乳手术比例差异有统计学意义(P<0.01),预后生存率差异无统计学意义(P>0.05)。结论发病年轻是双侧原发性乳腺癌发生的危险因素,双侧原发性乳腺癌各分子亚型的三阴性乳腺癌组织学Ⅲ级患者明显多于其他亚型,双侧原发性乳腺癌保乳术与同期单侧乳腺癌相比,其无瘤生存率差异无统计学意义(P>0.05)。 Objective To analyze the risk factors, molecular types, surgical methods of simultaneous bilateral primary breast cancer (BPBC) and assess its prognosis. Methods The age of 13 patients with simultaneous BPBC and contemporary patients with unilateral breast cancer (UBC) was analyzed;The clinical data of simultaneous BPBC was studied; According to the situation of the estrogen receptor ( ER), progesterone receptor (PR) and human epidermal growth factor receptor - 2 ( HER - 2 ), the simultaneous BPBC was divided into four kinds -Luminal A -type, Luminal B type, HER -2 type and triple- negative breast cancer (TNBC), The clinical and pathological features of the molecular subtypes and the treatment of BPBC and UBC were analyzed. Results The patients suffering from BPBC were younger than those of UBC. The patients suffering from the histological grade 111 of TNBC were much more than those from other subtypes (P 〈 0.05 ) ; There was no statistical difference about the molecular subtypes in the lymph node metastasis ( P 〉 0.05 ). There were significant differences in the proportion of breast- conserving surgery between patients of BPBC and UBC, and there was no obvious difference in the prognosis of survival. Conclusion Young age is the risky factor of BPBC. The patients suffering from the histological grade ]U of TNBC are much more than those from other subtypes. There is no difference in the disease - free survival between the conserving surgery of simultaneous BPBC and that of UBC.
作者 于晶晶
出处 《河北医科大学学报》 CAS 2012年第5期519-521,共3页 Journal of Hebei Medical University
关键词 乳腺肿瘤 外科手术 治疗结果 breast neoplasms surgical procedures, operative treatment outcome
  • 相关文献

参考文献10

  • 1WANG T,LIU H,CHEN KX,et al. The risk factors and prognosis of bilateral primary breast cancer: a comparative study with unilateral breast cancer [ J ]. Oncol Res, 2011,19 ( 3/4 ) : 171 - 178. 被引量:1
  • 2杨钱,陈洁,李宏江,于淼,田春祥,吕青.不同分子亚型乳腺癌的临床病理特征及预后分析[J].中华肿瘤杂志,2011,33(1):42-46. 被引量:53
  • 3IHEMELANDU CU, LEFFALL LJ, DEWITrY RL, et al. Molecular breast cancer subtypes in premenopausal and postmenopausal African - American women: age - specific prevalence and survival [ J ]. J Surg Res, 2007,143 ( 5 ) : 109 - 118. 被引量:1
  • 4阚秀编著..乳腺癌临床病理学[M],1993:314.
  • 5<乳腺癌HER2检测指南>编写组,霍临明.乳腺癌HER2检测指南[J].中华病理学杂志,2006,35(10):631-633. 被引量:165
  • 6KHEIRELSEID EA,JUMUSTAFA H, MILLER N, et al. Bilateral breast cancer: analysis of incidence, outcome, survival and disease characteristics [ J]. Breast Cancer Res Treat, 2011,126 (1) :131 -140. 被引量:1
  • 7DE LAURENTIIS M, CIANNIELLO D, CAPUTO R, et al. Treatment of triple negative breast cancer (TNBC): current options and future perspectives [ J ]. Cancer Treat Rev, 2010,36 ( Suppl 3 ) : $80 - $86. 被引量:1
  • 8张慧明,张保宁,宣立学,赵平.可手术的不同分子亚型乳腺癌的临床特征和生存分析[J].中华肿瘤杂志,2009,31(6):447-451. 被引量:30
  • 9FREEDMAN LM, BUCHHLZ TA, THAMER HD, et al. Local - regional control in breast cancer patients with a possible genetic predisposition[ J ]. Int Radiat Oncol Biol Phys, 2010,48 ( 7 ) : 951 - 957. 被引量:1
  • 10GILROY JS, MORRIS CG, MENDENHALL NP. Breast conserving therapy in patients with bilateral breast cancer: do today "s treatment choices burn bridges for tomorrow[ J]. Int Radiat Oncol Biol Phys,2005,62(2) :379 -385. 被引量:1

二级参考文献35

  • 1<乳腺癌HER2检测指南>编写组,霍临明.乳腺癌HER2检测指南[J].中华病理学杂志,2006,35(10):631-633. 被引量:165
  • 2张清媛,赵文辉,康欣梅.c-erbB1 c-erbB2和丝裂原活化蛋白激酶与乳腺癌三苯氧胺耐药的关系[J].中华肿瘤杂志,2006,28(11):826-830. 被引量:6
  • 3Pemu CM, Sφrlie T, Elsen MB, et al. Molecular portraits of human breast tumors. Nature, 2000, 406:747-752. 被引量:1
  • 4Kyndi M, SOrensen FB, Knudsen H, et al. Estrogen receptor, progesterone receptor, HER-2, and response to postmastectomy radiotherapy in high-risk breast cancer: the Danish Breast Cancer Cooperative Group. J Clin Oncol, 2008, 26 : 1419-1426. 被引量:1
  • 5Liedtke C, Mazouni C, Hess KR, et al. Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer. J Clin Oncol, 2008, 26:1275-1281. 被引量:1
  • 6Dent R, Trudeau M, Pritchard KI, et al. Triple-negative breast cancer: clinical features and patterns of recurrence. Clin Cancer Res, 2007, 13:4429-4434. 被引量:1
  • 7Ihemelandu CU, Leffall LD Jr, Dewitty RL, et al. Molecular breast cancer subtypes in premenopausal and postmenopausal African- American women: age-specific prevalence and survival. J Surg Res, 2007, 143:109-118. 被引量:1
  • 8Bauer KR, Brown M, Cress RD, et al. Descriptive analysis of estrogen receptor ( ER ) -negative, progesterone receptor ( PR ) -negative, and HER2-negative invasive breast cancer, the so-called triple- negative phenotype: a population-based study from the California cancer Registry. Cancer, 2007, 109 : 1721-1728. 被引量:1
  • 9Rakha EA, Ei-Sayed ME, Green AR, et al. Prognostic markers in triple-negative breast cancer. Cancer, 2007, 109:25-32. 被引量:1
  • 10Badve S, Turbin D, Thorat MA, et al. FOXA1 expression in breast cancer--correlation with luminal subtype A and survival. Clin Cancer Res. 2007. 13:4415-4421. 被引量:1

共引文献229

同被引文献34

引证文献3

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部